Form 4 for IBRX ImmunityBio, Inc.
Accepted 2026-01-05 00:00:00 ET · period of report 2025-12-31 · accession 0001848899-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2025-12-31 | IBRX | Sachs David C. | CFO | F - Tax | $1.98 | -15.4K | 240.6K | -6% | -$30.6K |
| D | 2026-01-05 | 2025-12-31 | IBRX | Sachs David C. | CFO | M - OptEx | $0.00 | +30.4K | 256.0K | +13% | $0 |
| D | 2026-01-05 | 2025-12-31 | IBRX | Sachs David C. | CFO | M - OptEx | $0.00 | -30.4K | 45.6K | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-31 | F | D | 15,435 | $1.98 | 240,582 | D | — | — | (F2) On December 31, 2025, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on December 30, 2025 was the settlement price used to calculate the shares withheld. |
| 2 | Common | Common Stock | 2025-12-31 | M | A | 30,397 | $0.00 | 256,017 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock. |
| 3 | Derivative | Restricted Stock Units | 2025-12-31 | M | D | 30,397 | $0.00 | 45,602 | D | — · — to — | 30,397 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock. (F3) 17,242 of the RSUs vested on December 9, 2021. Five percent (5%) of the remaining 151,989 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2025; and the remaining RSUs will vest on December 31, 2026. |